blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1377570

EP1377570 - SUBSTITUTED 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THE USE OF THE SAME AS SELECTIVE LIGANDS OF THE ADENOSINE RECEPTOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.03.2010
Database last updated on 17.07.2024
Most recent event   Tooltip19.03.2010No opposition filed within time limitpublished on 21.04.2010  [2010/16]
Applicant(s)For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
[2009/38]
Former [2009/37]For all designated states
Bayer Schering Pharma AG
Müllerstrasse 178
13353 Berlin / DE
Former [2009/20]For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
Former [2004/02]For all designated states
Bayer HealthCare AG
51368 Leverkusen / DE
Inventor(s)01 / ROSENTRETER, Ulrich
Obere Rutenbeck 6
42349 Wuppertal / DE
02 / KRÄMER, Thomas
Schneewittchenweg 37
42111 Wuppertal / DE
03 / VAUPEL, Andrea
Rütiring 23
CH-4125 Riehen / CH
04 / HÜBSCH, Walter
Wildsteig 22
42113 Wuppertal / DE
05 / DIEDRICHS, Nicole
Laurentiusstrasse 12
42103 Wuppertal / DE
06 / KRAHN, Thomas
Wiener Strasse 29
58135 Hagen / DE
07 / DEMBOWSKY, Klaus
289 Shawmut Avenue
Boston, MA 02118 / US
08 / STASCH, Johannes-Peter
Alfred-Nobel-Str. 109
42651 Solingen / DE
09 / SHIMADA, Mitsuyuki
4-7-905, Kyobate Jikata Higashigawa-cho
Nara 630-8323 / JP
 [2004/10]
Former [2004/02]01 / ROSENTRETER, Ulrich
Obere Rutenbeck 6
42349 Wuppertal / DE
02 / KRÄMER, Thomas
Schneewittchenweg 37
42111 Wuppertal / DE
03 / VAUPEL, Andrea
Rütiring 23
CH-4125 Riehen / CH
04 / HÜBSCH, Walter
Wildsteig 22
42113 Wuppertal / DE
05 / DIEDRICHS, Nicole
Laurentiusstrasse 12
42103 Wuppertal / DE
06 / KRAHN, Thomas
Wiener Strasse 29
58135 Hagen / DE
07 / DEMBOWSKY, Klaus
289 Shawmut Avenue
Boston, MA 02118 / US
08 / STASCH, Johannes-Peter
Alfred-Nobel-Str. 109
42651 Solingen / DE
09 / SHIMADA, Mitsuyuki
4-7-905, Kyobate, Jikata
Nara 630-8323 / JP
Application number, filing date02757721.225.03.2002
[2004/02]
WO2002EP03303
Priority number, dateDE200111594530.03.2001         Original published format: DE 10115945
[2004/02]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO02079196
Date:10.10.2002
Language:DE
[2002/41]
Type: A1 Application with search report 
No.:EP1377570
Date:07.01.2004
Language:DE
The application published by WIPO in one of the EPO official languages on 10.10.2002 takes the place of the publication of the European patent application.
[2004/02]
Type: B1 Patent specification 
No.:EP1377570
Date:13.05.2009
Language:DE
[2009/20]
Search report(s)International search report - published on:EP10.10.2002
ClassificationIPC:C07D405/04, C07D213/85
[2004/02]
CPC:
C07D405/04 (EP,US); A61P3/10 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/06 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D213/85 (EP,US) (-)
Designated contracting statesDE,   ES,   FR,   GB,   IT [2009/20]
Former [2004/02]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:SUBSTITUIERTE 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINE UND IHRE VERWENDUNG ALS ADENOSINREZEPTOR SELEKTIVE LIGANDEN[2004/02]
English:SUBSTITUTED 2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES AND THE USE OF THE SAME AS SELECTIVE LIGANDS OF THE ADENOSINE RECEPTOR[2004/02]
French:2-CARBA-3,5-DICYANO-4-ARYL-6-AMINOPYRIDINES SUBSTITUES ET LEUR UTILISATION EN TANT QUE LIGANDS SELECTIFS DU RECEPTEUR DE L'ADENOSINE[2004/02]
Entry into regional phase30.10.2003National basic fee paid 
30.10.2003Designation fee(s) paid 
30.10.2003Examination fee paid 
Examination procedure23.09.2002Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.10.2003Examination requested  [2004/02]
06.03.2006Despatch of a communication from the examining division (Time limit: M06)
20.10.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
12.12.2006Reply to a communication from the examining division
04.11.2008Communication of intention to grant the patent
26.02.2009Fee for grant paid
26.02.2009Fee for publishing/printing paid
Opposition(s)16.02.2010No opposition filed within time limit [2010/16]
Request for further processing for:12.12.2006Request for further processing filed
12.12.2006Full payment received (date of receipt of payment)
Request granted
01.02.2007Decision despatched
Fees paidRenewal fee
31.03.2004Renewal fee patent year 03
31.03.2005Renewal fee patent year 04
31.03.2006Renewal fee patent year 05
02.04.2007Renewal fee patent year 06
31.03.2008Renewal fee patent year 07
22.03.2008Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0705820  (BAYER AG [DE]) [A] 1-8 * column W *;
 [A]EP0282904  (BOEHRINGER BIOCHEMIA SRL [IT]) [A] 1-8 * column W *;
 [A]WO9919302  (CERMOL SA [CH], et al) [A] 1-8 * column W *;
 [A]WO9727177  (US HEALTH [US], et al) [A] 1-8 * column W *;
 [PX]WO0162233  (HOFFMANN LA ROCHE [CH]) [PX] 1-8 * column W *;
 [PA]WO0125210  (BAYER AG [DE], et al) [PA] 1-8 * column W *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.